Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(33)
OTHER(3)
Biospecimen Collection
4 trials
not_applicablephase_2
city-of-hope-medical-center
Computed Tomography
3 trials
phase_2
city-of-hope-medical-center
Questionnaire Administration
3 trials
not_applicablephase_2
city-of-hope-medical-center
Stereotactic Body Radiation Therapy
3 trials
phase_1phase_2
city-of-hope-medical-center
Positron Emission Tomography
3 trials
phase_2
city-of-hope-medical-center
Survey Administration
2 trials
not_applicablephase_2
city-of-hope-medical-center
Electronic Health Record Review
2 trials
not_applicable
city-of-hope-medical-center
Best Practice
2 trials
not_applicable
city-of-hope-medical-center

+13 more interventions

21 unique interventions2 categories

Analytics

Trial Phases

Phase 11
Phase 23

Trial Status

Completed1
Recruiting5
Other1

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT07225855Not ApplicableRecruiting
Geriatric Assessment and Management for Older Adults Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer and Their Family Caregivers
Localized Head and Neck Carcinoma
PrincipalinvestigatorStart date: 2026-08-25
NCT06014827Phase 2Recruiting
Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma
Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
PrincipalinvestigatorStart date: 2024-10-21
NCT06139627Not ApplicableRecruiting
Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy
Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8
PrincipalinvestigatorStart date: 2024-05-21
NCT05830058Phase 2Recruiting
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
Lung Non-Small Cell CarcinomaMalignant Solid NeoplasmMelanoma+1 more
PrincipalinvestigatorStart date: 2023-11-29
NCT05085496Phase 1Recruiting
Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC
Locally Advanced Skin Squamous Cell CarcinomaResectable Skin Squamous Cell CarcinomaUnresectable Skin Squamous Cell Carcinoma
PrincipalinvestigatorStart date: 2022-04-19
NCT03902535Completed
Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their Caregivers
CaregiverHead and Neck CarcinomaLung Carcinoma+18 more
PrincipalinvestigatorStart date: 2019-03-08
NCT05840770Phase 2Withdrawn
Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer
Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainStage IV Lung Cancer AJCC v8
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sriram Yennu

M.D. Anderson Cancer Center

Related
12 trials

Shared therapeutic areas:

Head and Neck CarcinomaLung Non-Small Cell CarcinomaMalignant Solid Neoplasm+7 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Aung Naing, Md

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Metastatic Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Stage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

William D Figg, Pharm.D.

National Cancer Institute (NCI)

Related
11 trials

Shared therapeutic areas:

Lung CarcinomaMelanomaCarcinoma, Renal Cell

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Michael Schweizer

Fred Hutch/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Metastatic Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Metastatic Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Jane Robertson

AstraZeneca

Related
10 trials

Shared therapeutic areas:

Carcinoma, Renal Cell
Similarity Score1%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Related
19 trials

Shared therapeutic areas:

Carcinoma, Renal Cell
Similarity Score1%

Deborah E Citrin, M.D.

National Cancer Institute (NCI)

Related
13 trials

Shared therapeutic areas:

Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT07225855Not ApplicablePrincipalInvestigator

Geriatric Assessment and Management for Older Adults Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer and Their Family Caregivers

Localized Head and Neck Carcinoma
Recruiting
NCT06014827Phase 2PrincipalInvestigator

Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma

Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
Recruiting
NCT06139627Not ApplicablePrincipalInvestigator

Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy

Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8
Recruiting
NCT05830058Phase 2PrincipalInvestigator

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

Lung Non-Small Cell CarcinomaMalignant Solid NeoplasmMelanoma+1 more
Recruiting
NCT05085496Phase 1PrincipalInvestigator

Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC

Locally Advanced Skin Squamous Cell CarcinomaResectable Skin Squamous Cell CarcinomaUnresectable Skin Squamous Cell Carcinoma
Recruiting
NCT03902535PrincipalInvestigator

Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their Caregivers

CaregiverHead and Neck CarcinomaLung Carcinoma+18 more
Completed
NCT05840770Phase 2PrincipalInvestigator

Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer

Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainStage IV Lung Cancer AJCC v8
Withdrawn

All 7 trials loaded